All In Biotech

Drug Trial Radar · NCT01715714

Statin Recapture Therapy Before Coronary Artery Bypass Grafting

Last checked: Nov 19, 2026Latest source record: Jul 22, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 2,630 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,630

Actual

Start

Nov 7, 2012

Primary completion

Apr 24, 2019

Study completion Sep 27, 2020

Sponsor

Lead sponsor
University of CologneAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
German Federal Ministry of Education and Research
First posted
Oct 29, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Patients with coronary artery disease requiring coronary artery bypass grafting (CABG) are at risk for postoperative complications after surgery. The StaRT-CABG trial is the first large-scale (2,630 patients) that will investigate whether an additional treatment with statins (lipid-lowering medication) in high doses before CABG surgery can reduce the incidence of major post-surgery complications including death, myocardial infarction and stroke. The StaRT-CABG trial will be recruiting patients from 8 cardiac surgery centres in Germany and is expected to provide relevant clinical data on the efficacy of this novel treatment in order to optimize the care for all patients undergoing CABG.

Conditions

  • Coronary Artery Disease

Interventions

  • Statin Recapture TherapyDrug

    Given 12h and 2h before CABG

  • PlaceboDrug

    Given 12h and 2h before CABG.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Major adverse cardiocerebral events (MACCE) within 30 days after CABG.Time frame: 30 days after Surgery

Locations

10 sites in 1 country. Site status is shown where the registry gives one.

  • Heart Center Freiburg-Bad Krozingen

    Freiburg im Breisgau, Baden-Wurttemberg, Germany

  • Heart Center Bad Neustadt

    Bad Neustadt an der Saale, Bavaria, Germany

  • University of Aachen

    Aachen, North Rhine-Westphalia, Germany

  • Heart Center Bad Oeynhausen

    Bad Oeynhausen, North Rhine-Westphalia, Germany

  • University of Bochum

    Bochum, North Rhine-Westphalia, Germany

  • University of Bonn

    Bonn, North Rhine-Westphalia, Germany

  • University of Cologne

    Cologne, North Rhine-Westphalia, Germany

  • University of Essen

    Essen, North Rhine-Westphalia, Germany

  • University of Muenster

    Münster, North Rhine-Westphalia, Germany

  • Helios Heart Center Wuppertal

    Wuppertal, North Rhine-Westphalia, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.